Key facts
- This page summarizes Emmanuel Heymann's Form 4 filing for CYABRA, INC. (CYAB).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 31 Mar 2026, 21:08.
Emmanuel Heymann - 27 Mar 2026 Form 4 Insider Report for CYABRA, INC. (CYAB)
- Reporting relationship
- Chief Revenue Officer
- Issuer ticker
- CYAB
- Reported as of
- 27 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 Mar 2026, 21:08:33 UTC
- Next SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Yael Sandler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Emmanuel Heymann filed Form 4 for CYABRA, INC. (CYAB) on 31 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002045608
Primary reporting owner
Heymann Emmanuel
- Relationship
- Chief Revenue Officer
- Address
- C/O CYABRA, INC. 13 GERSHON SHATZ, TEL AVIV, ISRAEL
- Signature
- /s/ Yael Sandler, Attorney-in-Fact
- Signature date
- 31 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYAB
transaction
Derivative
Stock Option(Right to Buy)
Award
- Transaction value
- Shares
- +25,264
- Change %
- Price
- Shares after
- 25,264
- Date
- 27 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,264
- Exercise price
- $1.00
- Footnotes
- F1, F2, F3
CYAB
transaction
Derivative
Stock Option(Right to Buy)
Award
- Transaction value
- Shares
- +28,883
- Change %
- Price
- Shares after
- 28,883
- Date
- 27 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,883
- Exercise price
- $7.53
- Footnotes
- F2, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Pursuant to the terms of the January 2023 Replacement Option (as defined below), the January 2023 Replacement Option has vested in part and shall vest over a period of three (3) years and ten (10) months as follows: The January 2023 Replacement Option vest over a period of three (3) years and ten (10) months as follows: Twenty-five percent (25%) vested upon the lapse of 10 months from January 1, 2023 (the "2023 Vesting Commencement Date") and the remaining 75% of the shares subject to the January 2023 Replacement Option has vested and shall vest on equal portions upon the lapse of the last day of each subsequent month thereafter, so that the January 2023 Replacement Option shall be fully vested by the thirty-sixth (36) month from the 2023 Vesting Commencement Date.
Footnote F2
Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.
Footnote F3
Pursuant to the Merger Agreement, options to purchase an aggregate of 7,000 ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") were, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein under the Cyabra, Inc. 2026 Omnibus Incentive Plan (the "2026 Plan"), subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time (the "January 2023 Replacement Option").
Footnote F4
Pursuant to the terms of the January 2025 Replacement Option (as defined below), the January 2025 Replacement Option has vested in part and shall vest over a period of three (3) years and ten (10) months as follows: The January 2025 Replacement Option shall vest over a period of three (3) years and ten (10) months as follows: Twenty-five percent (25%) vested upon the lapse of 10 months from January 1, 2025 (the "2025 Vesting Commencement Date") and the remaining 75% of the shares subject to the January 2025 Replacement Option have vested and shall vest on equal portions upon the lapse of the last day of each subsequent month thereafter, so that the January 2025 Replacement Option shall be fully vested by the thirty-sixth (36) month from the 2025 Vesting Commencement Date, pursuant to the 2026 Plan.
Footnote F5
Pursuant to the Merger Agreement, options to purchase an aggregate of 8,000 ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the Effective Time were, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein under the 2026 Plan, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time (the "January 2025 Replacement Option").